International PR

press release

Title Exosome Market Forces
writer exocobio
date 2020-07-30
 

  Exosome-related technologies have been developing rapidly



over the past few years and substantial growth is expected for



the market as they get integrated into the fields of liquid biopsy,



precision medicine and regenerative medicine.




  In particular, cancer derived exosomes influence the invasive  



potential of cells by regulating angiogenesis, metastasis, and



immunity, making them an extremely useful source of



biomarkers for use in cancer detection, diagnosis, and 



therapeutic selection.




  In May 2017, ExCoBio Inc. raised US $11 million in a Series



A funding round.  ExoCoBio is a venture-backed startup that



develops exosome- based cosmeceuticals and



biopharmaceuticals for skin and tissue regeneration that is



headquartered in South Korea Companies Mentioned Include:





¡¤        Anjarium Biosciences

¡¤        Avalon GloboCare Corp.

¡¤        Beckman Coulter

¡¤        Capricor Therapeutics

¡¤        Cavadis B.V.

¡¤        Cell Guidance Systems

¡¤        Codiak Biosciences

¡¤        CosmoBio USA

¡¤        Creative Medical Technologies Holdings

¡¤        Exiqon

¡¤        ExoCoBio Inc.

¡¤        Exerkine Corporation

¡¤        Exopharm

¡¤        Exosome Diagnostics

¡¤        Evox Therapeutics

¡¤        Exogenus Therapeutics

¡¤        Exosome Sciences

¡¤        Exosomics Siena SpA

¡¤        Exostemtech Co. Ltd.

¡¤        Exovita Biosciences

¡¤        Galen Lab Supplies

¡¤        Guangzhou Selaira Stem Cell Technology Co., Ltd

¡¤        HansaBioMed Life Sciences

¡¤        iZon Science

¡¤        Kimera Labs

¡¤        Lonza

¡¤        Miltenyi Biotec

¡¤        Norgen Biotek

¡¤        ReNeuron

¡¤        RoosterBio

¡¤        Unicyte AG

¡¤        VivaZome Therapeutics

¡¤        ZenBio

                                                                                                <BioInformant> 2018. 3.23

 URL : https://bioinformant.com/exosome-market-forces/


´Ù¿î·Îµå¼ö 0